MetaADEDB 2.0 @ LMMD
Rocuronium
(YXRDKMPIGHSVRX-OOJCLDBCSA-N)
Structure
SMILES
C=CC[N+]1(CCCC1)[C@H]1C[C@@H]2[C@]([C@H]1OC(=O)C)(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)C[C@@H]([C@H](C2)O)N1CCOCC1
Type(s)
Approved
ATC code(s)
M03AC09
Molecular Formula:
C32H53N2O4+
Molecular Weight:
529.774
Log P:
4.3042
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
59
CAS Number(s):
119302-91-9; 143558-00-3
Synonym(s)
1.
Rocuronium
2.
1-(17-(Acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium
3.
Esmeron
4.
Esmerone
5.
ORG 9426
6.
ORG-9426
7.
Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide
8.
Rocuronium Bromide
9.
Zemuron
10.
ORG9426
External Link(s)
MeSHD000077123
PubChem Compound441290
ChEBI8884
CHEMBLCHEMBL1201244
DrugBankDB00728
DrugCentral2396
IUPHAR/BPS Guide to PHARMACOLOGY4003
KEGGcpd:C07556
Therapeutic Target DatabaseD0L5CZ
ZINC53229445
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 34
Canada Vigilance: 11
Canada Vigilance
US FAERS
2HypotensionFAERS: 1112066744CTD
SIDER
US FAERS
3Cardiac ArrestFAERS: 6US FAERS
4Anaphylactic shockFAERS: 5SIDER
US FAERS
5BradycardiaFAERS: 5OFFSIDES
US FAERS
6BronchospasmFAERS: 5SIDER
US FAERS
7Respiratory arrestFAERS: 5US FAERS
8HypoventilationFAERS: 3US FAERS
9Product quality issueFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
10UrticariaFAERS: 3US FAERS
11Drug effect incompleteFAERS: 2US FAERS
12ErythemaFAERS: 2US FAERS
13FlushingFAERS: 2US FAERS
14HypoxiaFAERS: 2OFFSIDES
US FAERS
15Inadequate analgesiaFAERS: 2US FAERS
16Product complaintFAERS: 2US FAERS
17Product measured potency issueFAERS: 2US FAERS
18Product packaging quantity issueFAERS: 2US FAERS
19Product substitution issueFAERS: 2US FAERS
20SyncopeFAERS: 2US FAERS
21TachycardiaFAERS: 212066744CTD
SIDER
US FAERS
22Wrong drug administeredFAERS: 2OFFSIDES
US FAERS
23AcceleromyographyFAERS: 1US FAERS
24Accidental exposure to product by childFAERS: 1US FAERS
25Anaphylactoid ReactionFAERS: 1SIDER
US FAERS
26AstheniaFAERS: 1US FAERS
27DiplopiaFAERS: 1US FAERS
28Drug administration errorFAERS: 1US FAERS
29Drug dispensing errorFAERS: 1US FAERS
30Drug effect delayedFAERS: 1US FAERS
31Drug effect variableFAERS: 1US FAERS
32DysarthriaFAERS: 1US FAERS
33Endotracheal intubation complicationFAERS: 1OFFSIDES
US FAERS
34Hypersensitivity myocarditisFAERS: 1US FAERS
35Incorrect route of product administrationFAERS: 1US FAERS
36Liquid product physical issueFAERS: 1US FAERS
37Manufacturing materials issueFAERS: 1US FAERS
38MyalgiaFAERS: 125006369CTD
US FAERS
39MyocarditisFAERS: 1US FAERS
40OverdoseFAERS: 1US FAERS
41Pharmaceutical product complaintFAERS: 1US FAERS
42Procedural complicationFAERS: 1OFFSIDES
US FAERS
43Product label confusionFAERS: 1US FAERS
44Pulmonary congestionFAERS: 1US FAERS
45Respiratory ParalysisFAERS: 1US FAERS
46ShockFAERS: 1SIDER
US FAERS
47Sinus TachycardiaFAERS: 1US FAERS
48Therapeutic product ineffectiveFAERS: 1US FAERS
49Therapeutic response unexpectedFAERS: 1US FAERS
50TremorFAERS: 1US FAERS
51Tryptase increasedFAERS: 1US FAERS
52Unresponsive to stimuliFAERS: 1OFFSIDES
US FAERS
53Abdominal AbscessOFFSIDES
54Abdominal Compartment SyndromeOFFSIDES
55AcidosisOFFSIDES
56Acute otitis mediaOFFSIDES
57AdnexitisOFFSIDES
58Air EmbolismOFFSIDES
59Angle Closure GlaucomaOFFSIDES
60Anoxic EncephalopathyOFFSIDES
61Anticholinergic SyndromeOFFSIDES
62AnuriaOFFSIDES
63Aortic bruitOFFSIDES
64Aphthous StomatitisOFFSIDES
65ApneaOFFSIDES
66AsphyxiaOFFSIDES
67AsthmaSIDER
68Atrial tachycardiaOFFSIDES
69Atrial thrombosisOFFSIDES
70Auricular swellingOFFSIDES
71Autologous bone marrow transplantation therapyOFFSIDES
72AutomatismOFFSIDES
73Bifascicular blockOFFSIDES
74BlepharospasmOFFSIDES
75Blood creatine phosphokinase increasedOFFSIDES
76Blood phosphorus decreasedOFFSIDES
77Blood phosphorus increasedOFFSIDES
78Body TemperatureOFFSIDES
79Bone lesionOFFSIDES
80Brain DeathOFFSIDES
81Brain HypoxiaOFFSIDES
82Bronchial ObstructionOFFSIDES
83BronchopneumoniaOFFSIDES
84Bulbar palsyOFFSIDES
85Cardiac ventricular disorderOFFSIDES
86Cardio-respiratory distressOFFSIDES
87Cardiopulmonary BypassOFFSIDES
88Cardiovascular insufficiencyOFFSIDES
89Carotid bruitOFFSIDES
90Cataract operationOFFSIDES
91Cerebral disorderOFFSIDES
92Cerebral hypoperfusionOFFSIDES
93Circumstance or information capable of leading to medication errorOFFSIDES
94Clostridium difficile sepsisOFFSIDES
95Completed SuicideOFFSIDES
96Congenital tracheomalaciaOFFSIDES
97Creatinine renal clearance increasedOFFSIDES
98CyanosisOFFSIDES
99DermatitisSIDER
100DiverticulosisOFFSIDES
101Documented hypersensitivity to administered drugOFFSIDES
102Drug exposure during pregnancyOFFSIDES
103Drug toxicityOFFSIDES
104DysphoniaCanada Vigilance: 1Canada Vigilance
105DystoniaOFFSIDES
106Ejection Fraction DecreasedOFFSIDES
107Electrocardiogram ST-T changeOFFSIDES
108Electrocardiogram ST-T segment abnormalOFFSIDES
109Electrocardiogram abnormalSIDER
110Electromechanical dissociationOFFSIDES
111EmbolismOFFSIDES
112End-tidal CO2 increasedOFFSIDES
113EndocarditisOFFSIDES
114Endodontic procedureOFFSIDES
115Enterococcal infectionOFFSIDES
116Familial risk factorOFFSIDES
117Fatty LiverOFFSIDES
118FibrinolysisOFFSIDES
119Glasgow coma scaleOFFSIDES
120GlossectomyOFFSIDES
121GranulocytosisOFFSIDES
122Heart sounds abnormalOFFSIDES
123Hepatitis B positiveOFFSIDES
124HepatitisOFFSIDES
125HydrocephalusOFFSIDES
126HypercapniaOFFSIDES
127Hyperosmolar stateOFFSIDES
128HyperparathyroidismOFFSIDES
129HyperreflexiaOFFSIDES
130HypersensitivitySIDER
131HypokinesiaOFFSIDES
132Iliac artery occlusionOFFSIDES
133Implantable defibrillator insertionOFFSIDES
134Incorrect drug administration rateOFFSIDES
135Increased bronchial secretionOFFSIDES
136Infantile apnoeic attackOFFSIDES
137Infusion site erythemaOFFSIDES
138Infusion site nerve damageOFFSIDES
139Instillation site reactionOFFSIDES
140Intentional product use issueCanada Vigilance: 2Canada Vigilance
141Intervertebral Disc DegenerationOFFSIDES
142IntubationOFFSIDES
143Large intestine perforationOFFSIDES
144LaryngospasmOFFSIDES
145Left Ventricular HypertrophyOFFSIDES
146Left atrial dilatationOFFSIDES
147LeukoencephalopathyOFFSIDES
148Locked-In SyndromeOFFSIDES
149Long QT SyndromeOFFSIDES
150Low Cardiac Output SyndromeOFFSIDES
151Malignant HypertensionOFFSIDES
152Mechanical ventilationOFFSIDES
153MediastinoscopyOFFSIDES
154Metabolic acidosisOFFSIDES
155MicrostomiaOFFSIDES
156Muscle Rigidity19685109CTD
157Muscle Weakness9296427
11867378
18840103
CTD
158Muscle necrosisOFFSIDES
159Myoclonic EpilepsyOFFSIDES
160Myoclonus19100933CTD
161MyopathySIDER
162MyotoniaOFFSIDES
163NauseaSIDER
164NystagmusOFFSIDES
165Oral polypectomyOFFSIDES
166Oropharyngeal spasmOFFSIDES
167PCO2 increasedOFFSIDES
168Pain, Postoperative

View details

CTD
169Pain

View details

CTD
170Peritoneal DialysisOFFSIDES
171PneumopericardiumOFFSIDES
172PneumothoraxOFFSIDES
173Post procedural bile leakOFFSIDES
174Post procedural complicationOFFSIDES
175Postoperative Complications9067054
11942873
CTD
176Postoperative feverOFFSIDES
177Procedural hypotensionOFFSIDES
178Procedural nauseaOFFSIDES
179Product contaminationOFFSIDES
180Protein total increasedOFFSIDES
181PruritusSIDER
182Pulmonary HypertensionOFFSIDES
183Pulmonary vascular disorderOFFSIDES
184Recurrence of neuromuscular blockadeOFFSIDES
185Renal artery occlusionOFFSIDES
186Respiratory FailureOFFSIDES
SIDER
187Respiratory InsufficiencySIDER
188Respiratory distressCanada Vigilance: 1Canada Vigilance
189RhabdomyolysisOFFSIDES
190RhonchiSIDER
191SclerodermaOFFSIDES
192Septic ShockOFFSIDES
193SeptoplastyOFFSIDES
194Skeletal muscle paralysisSIDER
195Skin test positiveOFFSIDES
196Splenic InfarctionOFFSIDES
197SpondylolisthesisOFFSIDES
198StaringOFFSIDES
199Status EpilepticusOFFSIDES
200Stem cell transplantOFFSIDES
201Stevens-Johnson SyndromeOFFSIDES
202SubileusOFFSIDES
203Superficial ThrombophlebitisOFFSIDES
204Synovial CystOFFSIDES
205SyringomyeliaOFFSIDES
206Tachycardia, Ventricular18334037CTD
207Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
208Therapeutic product effect delayedCanada Vigilance: 1Canada Vigilance
209ThoracotomyOFFSIDES
210Thrombophlebitis20411396CTD
211Troponin I increasedOFFSIDES
212Troponin increasedOFFSIDES
213Urinary tract infection enterococcalOFFSIDES
214Urine ketone body presentOFFSIDES
215Uterine atrophyOFFSIDES
216Vascular resistanceSIDER
217Vasospasm, Intracranial18804883CTD
218VasospasmOFFSIDES
219Venous thrombosis limbOFFSIDES
220Ventricular Fibrillation18334037CTD
OFFSIDES
221Ventricular hypokinesiaOFFSIDES
222Victim of homicideOFFSIDES
223VomitingSIDER
224Weaning failureOFFSIDES
225WheezingSIDER
226Wound dehiscenceOFFSIDES
227anaphylaxis12066744
21414980
CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.